ALKS Stock Analysis: Buy, Sell, or Hold?
ALKS - Alkermes Inc. plc
$51.87
-0.07 (-0.13%)
▼
5d:
-5.93%
30d:
+18.32%
90d:
+55.49%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When ALKS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ALKS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALKS trades at premium valuation expecting 17.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ALKS trades at premium valuation expecting 17.9% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$61.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$38.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALKS is currently trading at $51.87, which is considered slightly high relative to its 30-day fair value range of $44.23 to $53.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 33.3) compared to its historical average (20.3). At these levels, the market is pricing in 17.9% annual earnings growth.
Technical Outlook: Technically, ALKS is in a strong uptrend. The price is currently testing key support at $50.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALKS is in a strong uptrend. The price is currently testing key support at $50.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$44.23 -
$53.45
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.8%
Protect Your Profits
Holding ALKS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($50.56)
- BULLISH: Expecting earnings turnaround to 17.9% growth with 28.2% revenue growth
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$44.23 -
$53.45
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$50.54
Resistance Level
$55.67
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.32
Wall Street Target
$50.56
(-2.5%)
Revenue Growth (YoY)
28.2%
Earnings Growth (YoY)
-67.0%
Profit Margin
9.8%
Valuation Premium vs History
+17.9% premium
PE vs Historical
33.3 vs 20.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+17.9%
(market-implied from PE analysis)
1-Year Target
$61.15
(+18%)
2-Year Target
$72.10
(+39%)
3-Year Target
$85.01
(+64%)
3-Yr Target (if PE normalizes)
(PE: 33→20)
PE COMPRESSION
$51.78
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.3, Growth: 58.2%)
$175.06
(+238%)
Base:
(SPY PE: 21.8, Growth: 58.2%)
$114.41
(+121%)
Bear:
(PE: 18.5, Growth: 58.2%)
$97.25
(+88%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (58x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 57.71 | Current EPS (TTM): $0.90
Bull Case
$98.81
(+91%)
Analyst growth 72.9%, PE expands to 63.5
Base Case
$89.83
(+73%)
Market implied 72.9%, PE stable at 57.7
Bear Case
$35.32
(-32%)
Severe decline -20.0%, PE contracts to 49.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALKS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
David Joseph Gaffin
SELL
2034 shares
2026-04-06
Craig C Hopkinson
SELL
9000 shares
2026-04-01
Christian Todd Nichols
SELL
6000 shares
2026-03-02
Featured in Portfolios
ALKS is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
Advanced ALKS Option Strategies
Professional options setups generated by AI based on today's ALKS price and gamma walls.
